Low High-Density Lipoprotein Cholesterol and Increased Cardiovascular Disease Risk: An Analysis of Statin Clinical Trials
- 1 November 2009
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 104 (10) , 3E-9E
- https://doi.org/10.1016/j.amjcard.2009.09.013
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Lipid Profile, Plasma Apolipoproteins, and Risk of a First Myocardial Infarction Among AsiansJournal of the American College of Cardiology, 2009
- High-Density Lipoprotein as a Therapeutic TargetJAMA, 2007
- Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart DiseaseCirculation, 2007
- Cardioprotective Effects of High-Density LipoproteinsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol TransportCirculation Research, 2005
- Are the effects of statins on HDL-cholesterol clinically relevant?European Heart Journal Supplements, 2004
- Statin Therapy in Acute Coronary SyndromesArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)The American Journal of Cardiology, 2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998